DepYmed, Inc.
Biotechnology Research
Farmingdale, New York, United States
2 employees
- Employees
- 2
- Contacts
- 1
- Emails
- 1
DepYmed, Inc. Overview
- Headquarters
- Farmingdale, New York, United States
- Website
- www.depymed.com
- Industry
- Biotechnology Research
- Employees
- 2
- Founded
- 2014
- Funding
- 1.1M
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
About DepYmed, Inc.
DepYmed is currently developing potent inhibitors of the enzyme PTP1B as therapeutics for cancer and rare diseases. In addition, DepYmed has developed a portfolio of novel small molecules with copper chelating properties that can be applied as potential therapeutic agents for multiple diseases including Wilson Disease and cancer.
DepYmed, Inc. Contact Details
- People in AeroLeads
- 1
- With contact data
- 1
- Email contacts
- 1
- 100.0% coverage
DepYmed, Inc. Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Peter Van Ess, Pharm.d., Ph.d. | Senior Vice President of Early | Minneapolis, Minnesota, United States |
Email
|
Compare Similar Companies to DepYmed, Inc.
Accredo Specialty Pharmacy
Hospitals And Health Care
Acadia Pharmaceuticals Inc.
Pharmaceutical Manufacturing
Prevail Partners LLC
Venture Capital And Private Equity Principals
Espervita Therapeutics
Pharmaceutical Manufacturing
Viamet Pharmaceuticals
Pharmaceutical Manufacturing
Vitranu
Biotechnology
Combangio, Inc.
Related company record
Amino Therapeutics
Pharmaceutical Manufacturing
CytoSPAR
Medical Equipment Manufacturing
Gromit Therapeutics
Biotechnology Research